Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000674

Drug Information
SynonymsQuinalbarbital; C12H18N2O3; DEA No. 2315; (+-)-5-Allyl-5-(1-methylbutyl)-barbituric acid; S4006_SIGMA; Seconal; CID5193; CHEMBL447; 29071-21-4; Secobarbitalum; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, (+-)- (9CI); Secobarbitale [DCIT]; Barbosec; 5-24-09-00235 (Beilstein Handbook Reference); 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, (+-)-; Meballymalum; 5-Allyl-5-(1-methylbutyl)malonylurea; Secobarbital (USP/INN); 5-(pentan-2-yl)-5-(prop-2-en-1-yl)-pyrimidine-2,4,6(1H,3H,5H)-trione; Seconal (TN); Secobarbital solution; Meballymal; Barbituric acid, 5-allyl-5-(1-methylbutyl)-; Secobarbitale; 76-73-3; Somosal; 5-ALLYL-5-(1-METHYLBUTYL)BARBITURIC ACID; LS-23756; (+-)-Secobarbital; Hypotrol; BRN 0225330; MolPort-003-959-501; BARBITURIC ACID, 5-ALLYL-5-(1-METHYLBUTYL)-, (+-)-; 5-allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione; AC1L1JT0; 5-(1-methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione; UNII-1P7H87IN75; Secobarbital [USAN:INN]; EINECS 200-982-2; LS-23757; Secobarbital suppository dosage form; S1503_FLUKA; S1503_SIGMA; AC1Q2UJO; 5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione; secobarbital; Seotal; DEA No. 2316; Evronal; Quinalbarbitone; CHEBI:9073; 5-pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione; D00430; Hyptran; Secobarbitalum [INN-Latin]; Secobarbitone; S4006_FLUKA; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-; Pramil; 5-Allyl-5-(1-methylbutyl)barbiturate; HSDB 3182
Trade NameSeconal
CompanyEli Lilly and Company
[ICD9: 307.41, 307.42, 327.0, 780.51, 780.52   ICD10: F51.0, G47.0]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C    
Therapeutic ClassHypnotics and Sedatives
CAS NumberCAS 76-73-3
PubChem Compound IDCID 5193.
PubChem Substance IDSID 149405.
SuperDrug ATC IDN05CA06
SuperDrug CAS ID000076733;
TargetGamma-aminobutyric acid receptor subunit alpha-1Antagonist[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 083281 To Reference
Ref 2DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6. Epub 2007 Nov 29. To Reference
Ref 3Effect of barbiturates on polyphosphoinositide biosynthesis and protein kinase C activity in synaptosomes. Neuropharmacology. 1989 Dec;28(12):1317-23. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543